JP2022543657A5 - - Google Patents

Info

Publication number
JP2022543657A5
JP2022543657A5 JP2022507624A JP2022507624A JP2022543657A5 JP 2022543657 A5 JP2022543657 A5 JP 2022543657A5 JP 2022507624 A JP2022507624 A JP 2022507624A JP 2022507624 A JP2022507624 A JP 2022507624A JP 2022543657 A5 JP2022543657 A5 JP 2022543657A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
antibody
cdr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022507624A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022543657A (ja
JP7692401B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/045466 external-priority patent/WO2021030209A1/en
Publication of JP2022543657A publication Critical patent/JP2022543657A/ja
Publication of JP2022543657A5 publication Critical patent/JP2022543657A5/ja
Application granted granted Critical
Publication of JP7692401B2 publication Critical patent/JP7692401B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022507624A 2019-08-09 2020-08-07 オステオポンチンに対する治療用抗体 Active JP7692401B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962884818P 2019-08-09 2019-08-09
US62/884,818 2019-08-09
PCT/US2020/045466 WO2021030209A1 (en) 2019-08-09 2020-08-07 Therapeutic antibodies against osteopontin

Publications (3)

Publication Number Publication Date
JP2022543657A JP2022543657A (ja) 2022-10-13
JP2022543657A5 true JP2022543657A5 (https=) 2023-08-07
JP7692401B2 JP7692401B2 (ja) 2025-06-13

Family

ID=74569814

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022507624A Active JP7692401B2 (ja) 2019-08-09 2020-08-07 オステオポンチンに対する治療用抗体

Country Status (8)

Country Link
US (2) US12351625B2 (https=)
EP (1) EP4010369A4 (https=)
JP (1) JP7692401B2 (https=)
KR (1) KR20220058554A (https=)
CN (1) CN114867746A (https=)
AU (1) AU2020331301A1 (https=)
CA (1) CA3146092A1 (https=)
WO (1) WO2021030209A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12605371B2 (en) 2020-07-31 2026-04-21 The Board Of Trustees Of The Leland Stanford Junior University Combination therapy for cancer

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4256901A (en) * 2000-03-23 2001-10-03 Glaxo Group Limited Method of screening for inhibitors of osteopontin
US20040234524A1 (en) * 2001-04-05 2004-11-25 Toshimitsu Uede Anti-osteopontin antibody and use thereof
US7241873B2 (en) * 2001-09-25 2007-07-10 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Recombinant anti-osteopontin antibody and use thereof
US20050040570A1 (en) * 2002-01-18 2005-02-24 Andreas Asselborn Method and device for determining the characteristics of molten metal
AU2004324192A1 (en) * 2004-10-13 2006-04-27 Genentech, Inc. Method for treating tumors using anti-osteopontin antibodies
EP2077325A4 (en) * 2006-09-11 2012-04-11 Immuno Biological Lab Co Ltd MONOCLONAL ANTIBODY AND ITS USE
JP5339748B2 (ja) 2008-03-11 2013-11-13 国立大学法人北海道大学 ヒトオステオポンチンの活性化を阻害する物質をスクリーニングする方法
CN102597001B (zh) 2009-08-19 2014-07-30 默克专利有限公司 在ffpe材料中用于检测整联蛋白复合体的抗体
EP2914629A1 (en) * 2012-11-05 2015-09-09 MAB Discovery GmbH Method for the production of multispecific antibodies
AU2015279712B2 (en) * 2014-06-26 2021-03-25 Yale University Compositions and methods to regulate renalase in the treatment of diseases and disorders
TW201623329A (zh) * 2014-06-30 2016-07-01 亞佛瑞司股份有限公司 針對骨調素截斷變異體的疫苗及單株抗體暨其用途
WO2016154623A2 (en) 2015-03-26 2016-09-29 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Anti-cd133 monoclonal antibodies and related compositions and methods
WO2018083237A1 (en) * 2016-11-03 2018-05-11 Roche Diagnostics Operations Inc. Novel anti-py520-ddr1 antibodies
US20190367602A1 (en) * 2016-12-12 2019-12-05 Synergenics, Llc Novel monoclonal antibodies to osteopontin

Similar Documents

Publication Publication Date Title
JP7464764B2 (ja) 抗ｒｏｒ１抗体とその作製及び使用方法
JP7547581B2 (ja) 腫瘍治療薬及びその応用
JP7685095B2 (ja) 多重特異性抗体とその作製及び使用方法
JP7356970B2 (ja) 多重特異性抗体とその作製及び使用方法
JP7399852B2 (ja) 多重特異性抗体とその作製及び使用方法
JP6923957B2 (ja) Ｄｓｇ２モノクローナル抗体およびその応用
RU2014113304A (ru) Анти-cd40-антитела, применение и методы
JP2023159380A (ja) ＰＤ－１とＴＧＦ－ｂｅｔａを標的とした四価二重特異性抗体、その製造方法および用途
WO2021244328A1 (zh) 一种抗pd-l1和her2的双特异性抗体
US12577314B2 (en) Anti-BCMA/anti-4-1BB bispecific antibodies and uses thereof
JP2025511135A5 (https=)
JP2022543657A5 (https=)
JP2026506070A (ja) 抗ｃｎｔｎ４抗体及びその使用
EP4144764A1 (en) TGFßR2 EXTRACELLULAR DOMAIN TRUNCATED MOLECULE, FUSION PROTEIN OF TGFßR2 EXTRACELLULAR DOMAIN TRUNCATED MOLECULE AND ANTI-EGFR ANTIBODY, AND ANTI-TUMOR USE OF FUSION PROTEIN
WO2022117003A1 (zh) 抗PD-L1/TGF-β双功能抗体及其用途
TW202146446A (zh) 一種抗pd-l1和egfr的四價雙特異性抗體
CA3176671C (en) Tgfbr2 extracellular domain truncated molecule, fusion protein of tgfbr2 extracellular domain truncated molecule and anti-egfr antibody, and anti-tumor use of fusion protein
Li et al. Antibodies and their multivalent constructs for cancer therapy
JP2025534036A (ja) 多重機能組み換え抗体およびその製造方法と使用
CN118891287A (zh) 抗cd73的抗体及其应用
CN121591904A (zh) 靶向Trop2和HER2的双特异性抗体及其制备方法与应用
HK40078463B (zh) 一种抗claudin18.2单克隆抗体、其制备方法及用途
HK40075930A (en) TGFβR2 EXTRACELLULAR DOMAIN TRUNCATED MOLECULE, FUSION PROTEIN OF TGFβR2 EXTRACELLULAR DOMAIN TRUNCATED MOLECULE AND ANTI-EGFR ANTIBODY, AND ANTI-TUMOR USE OF FUSION PROTEIN
HK40018991A (en) Multi-specific antibodies and methods of making and using thereof
HK40019010A (en) Multi-specific antibodies and methods of making and using thereof